Search

You searched for "lymphomas"

643 results found

Ocular toxicity secondary to deferoxamine

12 June 2026 | | EYE - Pathology, EYE - Imaging, EYE - Vitreo-Retinal
Patients with myelodysplastic syndromes can develop transfusion-related iron overload as they become dependent on recurrent blood transfusions [1]. Iron chelation therapy is indicated for the treatment of iron overload and one established example of this is deferoxamine. However, deferoxamine ocular...

Typical and atypical optic neuritis – diagnosis and initial management

1 June 2016 | | EYE - Neuro-ophthalmology
Optic neuritis is a relatively common presentation to ophthalmologists in the acute setting. The vast majority are cases of ‘typical’ optic neuritis (ON) but a smaller group of conditions, so-called, ‘atypical’ optic neuritides require a different work-up and management strategy....

Conservative management of concomitant strabismus

1 October 2019 | | EYE - General
The aim of management for all patients with strabismus should centre around four goals: to prevent amblyopia, to alleviate symptoms, to restore binocular single vision (BSV) and to improve ocular alignment. The conservative management options available for strabismus include observation,...

“I can see fine. Why do I need my eyes tested?”

2 December 2019 | | EYE - General
Are routine eye examinations really necessary? The author asks whether frequent appointments in low-risk patients with normal results are actually cost-effective. It’s recommended that most people should get their eyes tested every two years.” [1] This message is widely publicised...

Providing primary eyecare services during a global pandemic: the new normal

7 December 2020 | | EYE - General
It would be fair to say that 2020 hasn’t quite turned out to be the year that anyone predicted. Living with a global pandemic has become our reality and we are having to get used to many aspects of our...

Sexually transmitted conjunctivitis – the REALLY sticky eye

5 October 2020 | | EYE - Cornea, EYE - General
Let’s face it, patients with conjunctivitis don’t always produce the most stimulating consultations and most of the time we can manage them in auto-pilot. The prospect of delving into such a patient’s sexual history is not overly appealing, but this...

Pituitary tumours: why are they so often missed?

1 August 2017 | | EYE - Neuro-ophthalmology
Part 2: Clinical varieties, anatomical considerations and case report (see also Part 1 and Part 3) For ophthalmologists there are four types of pituitary tumour to be considered, three of which are named according to the hormone secreted, along with...

Pituitary tumours: why are they so often missed?

1 April 2017 | | EYE - Neuro-ophthalmology
Part 1: Introduction, historical background and Edinburgh connections (see also Part 2 and Part 3) Is there any ophthalmologist who has not missed a pituitary tumour? Hopefully this article will help those currently in practice to avoid such an embarrassment,...

Psychiatric Consequences of Ophthalmic Disease

1 December 2013 |
In part two of this series on ophthalmology and psychiatry, the authors will cover the possible psychiatric consequences of ophthalmic disease. The following conditions will be discussed: a. Black patch psychosis b. Psychological state in blindness c. Phobias in the...

Acute management of retrobulbar haemorrhage

1 February 2022 | | EYE - Orbit, EYE - Oculoplastic
The authors discuss the importance of rapid diagnosis and correct management of acute RBH presentation to avoid the risk of permanent blindness. Retrobulbar haemorrhage (RBH) is an ocular emergency that occurs due to arterial bleeding in the orbital cavity behind...

Dementia and visual impairment: what is the relationship and are we providing the best care?

1 February 2022 | | EYE - Cataract, EYE - Refractive, EYE - General
Carla Maden discusses the implications of living with both dementia and visual impairment, and how general medical junior doctors and ophthalmologists can help to alleviate this burden and improve the quality of life of such patients. Dementia and visual impairment...

An eye on novel anti-cancer agents: an evidence-based approach to external eye assessment

5 April 2022 | | EYE - Cornea, EYE - General
Novel anti-cancer therapies have led to significant advancement in cancer treatment, however, they can be associated with external eye complications. It is important to be mindful of such adverse effects during assessment of patients enrolled in clinical trials. Annually, approximately...